CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism

被引:188
作者
Dai, ZH
Li, Q
Wang, YN
Gao, G
Diggs, LS
Tellides, G
Lakkis, FG
机构
[1] Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, New Haven, CT USA
[2] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Surg, Sect Cardiothorac Surg, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Internal Med, Cardiol Sect, New Haven, CT 06510 USA
关键词
D O I
10.1172/JCI200419727
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
CD4(+)CD25(+) regulatory T (Treg) cells suppress naive T cell responses, prevent autoimmunity, and delay allograft rejection. It is not known, however, whether Treg cells suppress allograft rejection mediated by memory T cells, as the latter mount faster and stronger immune responses than their naive counterparts. Here we show that antigen-induced, but not naive, Treg cells suppress allograft rejection mediated by memory CD8(+) T cells. Suppression was allospecific, as Treg cells induced by third-party antigens did not delay allograft rejection. In vivo and in vitro analyses revealed that the apoptosis of allospecific memory CD8(+) T cells is significantly increased in the presence of antigen-induced Treg cells, while their proliferation remains unaffected. Importantly, neither suppression of allograft rejection nor enhanced apoptosis of memory CD8(+) T cells was observed when Treg cells lacked CD30 or when CD30 ligand-CD30 interaction was blocked with anti-CD30 ligand Ab. This study therefore provides direct evidence that pathogenic memory T cells are amenable to suppression in an antigen-specific manner and identifies CD30 as a molecule that is critical for the regulation of memory T cell responses.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 44 条
[1]  
Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745
[2]   Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice [J].
Amakawa, R ;
Hakem, A ;
Kundig, TM ;
Matsuyama, T ;
Simard, JJL ;
Timms, E ;
Wakeham, A ;
Mittruecker, HW ;
Griesser, H ;
Takimoto, H ;
Schmits, R ;
Shahinian, A ;
Ohashi, PS ;
Penninger, JM ;
Mak, TW .
CELL, 1996, 84 (04) :551-562
[3]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[4]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[5]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[6]  
Bowen MA, 1996, J IMMUNOL, V156, P442
[7]   Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs [J].
Chalasani, G ;
Dai, ZH ;
Konieczny, BT ;
Baddoura, FK ;
Lakkis, FG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) :6175-6180
[8]   Cutting edge: Secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool [J].
Dai, ZH ;
Lakkis, FG .
JOURNAL OF IMMUNOLOGY, 2001, 167 (12) :6711-6715
[9]  
Dai ZH, 1998, J IMMUNOL, V161, P1659
[10]  
Davies DK, 1999, INST PHYS CONF SER, V163, P3